3rd Health Programme 2014-2020
Joint action
JA-04-2016 – Antimicrobial resistance and
Health Care Associated Infections
Coordinator: INSERM
JA Aims
The main objective is to join forces to build an European program and to
define common policies to fight AMR and to control HCAI in line with
ongoing EU and international policies
Many national initiatives already exist. Our work is to look over the best
programs in each country and to get the best for this Joint Action and see
how cooperation at EU level can improve national AMR-related policies
However, we have to take into account the specificities of each country
(AMR epidemiology, health-care systems, population size, …)
Identify for each WP the institutions and/or research units which would be
highly relevant for the JA implementation
We need concrete outcome for the JA so the political intentions must lead
to practical actions shared by MS involved in the JA.
JA Objectives
Identifying and testing evidence-based measures to address AMR and
HCAI in different contexts and, based on the outcome of these tests,
provide recommendations to policy-makers.
Bringing together different networks of policy makers, experts and
organizations on AMR and HCAI working in different European and
International initiatives and projects relevant for policy decision.
Promoting (i) the One Health approach through a closer collaboration,
understanding and trust between the animal health and human health
sector, accounting for environmental issues, and (ii) the “One Health in all
policies” concept (health policies should have an intersectoral dimension)
in addition to the “Health in all policies” concept (all policies should have a
health dimension).
EU-JAMRAI
3rd Health programme 2016
4M€ EU budget
47 partners
22 countries
International organizations involved (OECD,
WHO Europe, ECDC, …)
Strong links with existing initiatives
EU-JAMRAI – Work Plan
WP#
Work Package Title
Leading
country
WP1
Management
France
WP2
Dissemination
Spain
WP3
Evaluation
Italy
WP4
Integration in National Policies and sustainability
France
WP5
Implementation of One Health national strategies Netherlands
and National Action Plans for AMR
WP6
Policies for prevention of HCAI and their
implementation
Greece
Sweden
WP7
Appropriate use of antimicrobials in human and
in animals
Norway
Spain
WP8
Awareness raising and communication
Spain
WP9
Prioritizing and implementing research and
innovation for public health needs
Norway
France
Expected outcomes
Support Member States in the development and implementation of national
strategies
Ensure a common approach at European level on the implementation of the
Global Action Plan.
Produce guidance documents and tools allowing Member States to improve
the fight against AMR at national, local, and health-care setting level
Enhance the implementation of organisational change and/or other methods
to enable sustainable improvements in practice by health care professionals
Strengthen the ‘One Health’ approach and coordination with relevant sectors
Promote awareness and commitment by governments and stakeholders to
ensure integration into national action plans.
Have a coordinated European response in regards to prioritizing and assisting
in the implementation of research and innovation to help achieve public
health-related AMR and HCAI goals and objectives
WP9
Prioritizing and implementing research and innovation
for public health needs
Task 9.1: Work with Member States to ensure that national
processes for research and innovation priority-setting are
grounded in a One Health and broad approach and fill the gap
with existing SRA such as that of the JPIAMR
Task 9.2: Explore and detail European strategies to implement
mechanisms to foster antimicrobial innovation and other
means to fight against AMR and HCAI
Task 9.3: Contribute to ensuring that evidence-informed
public health policies and practices related to combatting
AMR and HCAI are implemented
Conclusion
Promising project
Variety of actors
Focused on concrete tasks
=> Antimicrobial resistance: Yes we care !
Thank you